Neurologic Case Study

Patient Profile:

• Age: 68 years.
• Gender: Male.
• Medical History: Hypertension, Type 2 Diabetes Mellitus.
• Medications: Lisinopril, Metformin.
• Allergies: None.

Chief Complaint: The patient presents to the emergency department (ED) with a sudden onset of right-sided weakness and difficulty speaking that began approximately 1 hour prior to arrival.

Exhibits

What is a potential complication of the patient's condition?

Choice A reason: Idiopathic pulmonary fibrosis is a chronic, progressive lung disease characterized by scarring of the lung tissue. Tissue plasminogen activators (tPAs) are not used for this condition, as they are primarily designed to dissolve blood clots, not to address fibrotic changes in the lungs.

Choice B reason: Sarcoidosis is an inflammatory disease that affects multiple organs, particularly the lungs and lymph glands. It involves the growth of tiny collections of inflammatory cells called granulomas. Tissue plasminogen activators are not used in the treatment of sarcoidosis since the condition is not related to blood clots but rather to immune system dysregulation.

Choice C reason: Atelectasis is the complete or partial collapse of a lung or lobe of a lung due to alveoli deflation. The treatment typically focuses on re-expanding the lung tissue through techniques such as deep breathing exercises, bronchoscopy, or mechanical ventilation. Tissue plasminogen activators are not relevant for this condition, as they are used to dissolve blood clots, not to treat lung collapse.

Choice D reason: Pulmonary embolus (PE) is a blockage in one of the pulmonary arteries in the lungs, usually caused by blood clots that travel to the lungs from the legs or other parts of the body (deep vein thrombosis). Tissue plasminogen activators are used to treat PE because they can effectively dissolve the blood clots obstructing the pulmonary arteries, thereby restoring normal blood flow and preventing further complications.

Choice A reason: A blood pressure of 128/76 mm Hg is within the target range for a patient with hypertension, indicating that the current therapy is effectively managing the condition. This reading is below the generally accepted threshold for hypertension, which is 140/90 mm Hg.

Choice B reason: A blood pressure of 148/78 mm Hg is above the target range for hypertension management. This reading suggests that the patient may need an adjustment in their therapy to better control their blood pressure and reduce the risk of cardiovascular complications.

Choice C reason: A blood pressure of 98/56 mm Hg is too low and may indicate hypotension, which can be a concern, especially if the patient experiences symptoms like dizziness or fainting. This reading suggests that the patient's therapy may need to be adjusted to avoid excessively lowering blood pressure.

Choice D reason: A blood pressure of 128/92 mm Hg shows an elevated diastolic pressure, which is above the target range. This indicates that the patient's hypertension is not fully controlled, and adjustments in therapy may be needed to bring both systolic and diastolic pressures within the desired range.